Sliva K[Author] - Search Results

Year	Number of Results
1995	1
2004	1
2006	1
2007	2
2010	3
2011	2
2012	2
2013	2
2014	3
2015	3
2016	3
2019	1
2023	1
2024	0

1

Allergen-specific immunotherapy and evidence: A European regulatory perspective.

Bartel D, Bonertz A, Hartenstein D, Kaul S, Lauer I, Reeb C, Rösner-Friese K, Sliva K, Zimmer J, Vieths S, Mahler V. Bartel D, et al. Among authors: sliva k. Allergol Select. 2023 Dec 12;7:198-210. doi: 10.5414/ALX02413E. eCollection 2023. Allergol Select. 2023. PMID: 38143937 Free PMC article. Review.

2

Latest animal models for anti-HIV drug discovery.

Sliva K. Sliva K. Expert Opin Drug Discov. 2015 Feb;10(2):111-23. doi: 10.1517/17460441.2015.975201. Epub 2014 Oct 28. Expert Opin Drug Discov. 2015. PMID: 25350741 Review.

3

Selective gene silencing by viral delivery of short hairpin RNA.

Sliva K, Schnierle BS. Sliva K, et al. Virol J. 2010 Sep 21;7:248. doi: 10.1186/1743-422X-7-248. Virol J. 2010. PMID: 20858246 Free PMC article. Review.

4

From actually toxic to highly specific--novel drugs against poxviruses.

Sliva K, Schnierle B. Sliva K, et al. Virol J. 2007 Jan 15;4:8. doi: 10.1186/1743-422X-4-8. Virol J. 2007. PMID: 17224068 Free PMC article. Review.

5

Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.

Kraus B, Fischer K, Sliva K, Schnierle BS. Kraus B, et al. Among authors: sliva k. Virol J. 2014 Mar 26;11:58. doi: 10.1186/1743-422X-11-58. Virol J. 2014. PMID: 24669861 Free PMC article.

6

Cutaneous T-cell lymphoma cells are sensitive to rapamycin.

Kremer M, Sliva K, Klemke CD, Schnierle BS. Kremer M, et al. Among authors: sliva k. Exp Dermatol. 2010 Sep;19(9):800-5. doi: 10.1111/j.1600-0625.2010.01102.x. Epub 2010 Jul 14. Exp Dermatol. 2010. PMID: 20629739

7

The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.

Weber C, Sliva K, von Rhein C, Kümmerer BM, Schnierle BS. Weber C, et al. Among authors: sliva k. Antiviral Res. 2015 Jan;113:1-3. doi: 10.1016/j.antiviral.2014.11.001. Epub 2014 Nov 11. Antiviral Res. 2015. PMID: 25446334

8

Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.

Kraus B, Fischer K, Büchner SM, Wels WS, Löwer R, Sliva K, Schnierle BS. Kraus B, et al. Among authors: sliva k. PLoS One. 2013 Aug 30;8(8):e72756. doi: 10.1371/journal.pone.0072756. eCollection 2013. PLoS One. 2013. PMID: 24023643 Free PMC article.

9

Expression of human endogenous retrovirus-K coincides with that of micro-RNA-663 and -638 in germ-cell tumor cells.

Kraus B, Mönk B, Sliva K, Schnierle BS. Kraus B, et al. Among authors: sliva k. Anticancer Res. 2012 Nov;32(11):4797-804. Anticancer Res. 2012. PMID: 23155245

10

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.

Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS. Henß L, et al. Among authors: sliva k. Virol J. 2016 Aug 31;13(1):149. doi: 10.1186/s12985-016-0607-2. Virol J. 2016. PMID: 27581733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year